All Posts

We identified 5 stocks that are likely to move big on cancer readouts this Q1 2025. We classified these as either Big Mover or Suspected Big Mover catalysts depending on stock options volatility data. We highlight 5 of these catalysts in the graphics below. 👇   $ARVN Vepdegestrant (ARV-471) / Metastatic Breast Cancer / Phase 3 » Phase 3 VERITAC-2 trial designed to position vepdegestrant as a backbone ER-targeting therapy in BCA. » Ph2 VERITAC had favorable tolerability at bo

The 43rd Annual J.P. Morgan Health Care Conference  is taking place in San Francisco, CA from January 13-16, 2025 . "This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community." ( https://www.jpmorgan.com/about-us/events-conferences/health-care-conference ) Many of the smid-cap biopharm

We’re always excited to find bio/pharma companies nearing their therapeutic product launch! These 4 companies have FDA final approval decision (PDUFA) dates before the end of January: Atara Biotherapeutics (NASDAQ: ATRA ) Drug/Therapy: Tab-cel (tabelecleucel) Allogeneic T-cell immunotherapy Indication: Post-Transplant Lymphoproliferative Disease (PTLD) PDUFA date: January 15, 2025 BLA with priority review Biogen (NASDAQ: BIIB ) Drug/Therapy: Leqembi (Lecanemab) IV Maintenance

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move

How can hedge fund data help biotech investors? Hedge fund holdings can help you discover new investment ideas and get more conviction about your current holdings. For example, you can see how many top biotech or biopharma hedge funds hold your favorite companies or which tickers are the most popular tickers amongst top biotech or biopharma hedge funds. When you use hedge fund information, you leverage the expertise and resources of top hedge funds for your investment decisio

What biotech M&A data does BPIQ offer? Free: M&A Activity History Pro: M&A Activity History Elite: M&A Activity History M&A Our and Othe Picks Amp: M&A Activity History M&A Our and Othe Picks *See pictures below for visuals M&A Activity History: M&A Our and Othe Picks This article is NOT legal, investment or tax advice. Please do your own diligence before making any investment decisions.

What are Biotech Catalyst Events? Biotech catalyst events are significant milestones in the biopharmaceutical industry that can trigger substantial changes in stock prices. These events include clinical trial results, regulatory decisions, data presentations, and other developments that can impact the future prospects of biotech companies. Why are Biotech Catalyst Events Important for Retail Investors? Biotech catalyst events have a direct influence on the value of biotech st

What is a PDUFA Date? A Prescription Drug User Fee Act (PDUFA) date is a pivotal milestone for pharmaceutical companies. It marks the FDA's expected completion date for reviewing New Drug Applications (NDAs) and Biologics License Applications (BLAs) submitted by companies seeking approval for new drugs. PDUFA dates are essential for planning marketing strategies, informing investors, and anticipating the potential approval of a new treatment. Why are PDUFA Dates Important for

Why are Biomedical Conferences important? Biomedical conferences upcoming abstract release dates and meeting dates are important events because these can be major movers for stocks/companies depending on if new data is being released and presented. Sometimes these conference data readouts are just as big as if a company was announcing new data which means these meetings can cause company stocks to move up or down. Also, competing companies my release and present data that can

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move